share_log

4: Statement of changes in beneficial ownership of securities-Director SCANNON PATRICK J MD PHD

4: Statement of changes in beneficial ownership of securities-Director SCANNON PATRICK J MD PHD

4:持股變動聲明-董事 SCANNON PATRICK J MD PHD
美股SEC公告 ·  05/13 16:22
Moomoo AI 已提取核心訊息
Patrick J. Scannon, MD, PhD, reported a transaction related to Cassava Sciences Inc (SAVA) stock on May 9, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. Investors are advised to monitor the company's filings for further information regarding this transaction.
Patrick J. Scannon, MD, PhD, reported a transaction related to Cassava Sciences Inc (SAVA) stock on May 9, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. Investors are advised to monitor the company's filings for further information regarding this transaction.
醫學博士、帕特里克·斯坎農於2024年5月9日報告了一筆與木薯科學公司(SAVA)股票相關的交易。公告中未披露交易的具體細節,包括行動類型、狀態、所涉股份數量、股票性質、交易價格和交易後的持股情況。建議投資者關注公司的申報情況,以獲取有關該交易的更多信息。
醫學博士、帕特里克·斯坎農於2024年5月9日報告了一筆與木薯科學公司(SAVA)股票相關的交易。公告中未披露交易的具體細節,包括行動類型、狀態、所涉股份數量、股票性質、交易價格和交易後的持股情況。建議投資者關注公司的申報情況,以獲取有關該交易的更多信息。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息